Home
PLRZ
PLRZ News

Latest POLYRIZON LTD (PLRZ) News on January 19, 2025

GlobeNewswire

20 days ago

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

GlobeNewswire

a month ago

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

GlobeNewswire

a month ago

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

GlobeNewswire

a month ago

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

GlobeNewswire

2 months ago

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

ACCESSWIRE

3 months ago

Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)

GlobeNewswire

3 months ago

Polyrizon Announces Closing of $4.2 Million Initial Public Offering

Share on Social Networks: